MARKET

KHTRF

KHTRF

Knight Therapeut
OTCPK
8.46
+0.05
+0.59%
Closed 15:41 11/13 EST
OPEN
8.43
PREV CLOSE
8.41
HIGH
8.46
LOW
8.43
VOLUME
2.25K
TURNOVER
18.97K
52 WEEK HIGH
8.61
52 WEEK LOW
4.240
MARKET CAP
831.40M
P/E (TTM)
74.87
1D
5D
1M
3M
1Y
5Y
1D
Knight Therapeutics Earnings Call Signals Strong Growth Ahead
TipRanks · 11/08 00:03
Stifel Nicolaus Keeps Their Buy Rating on Knight Therapeutics (KHTRF)
TipRanks · 11/06 17:45
Knight Therapeutics price target raised to C$13 from C$11 at RBC Capital
TipRanks · 11/06 17:01
Knight Therapeutics price target raised to C$12.75 from C$12.25 at Stifel
TipRanks · 11/06 17:00
Knight Therapeutics price target raised to C$12.75 from C$11 at Canaccord
TipRanks · 11/06 16:50
Knight Therapeutics reports Q3 results
Seeking Alpha · 11/05 15:11
Knight Therapeutics Reports Record Nine-Month Growth and Portfolio Expansion
TipRanks · 11/05 12:08
*Knight Therapeutics 3Q Loss/Shr C$0.03 >GUD.T
Dow Jones · 11/05 11:38
More
About KHTRF
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company's principal business activity is developing, acquisition, in-licensing, out-licensing, manufacturing, marketing and distribution of pharmaceutical products, consumer health products and medical devices. It finances other life sciences companies and secures product distribution rights for Canada and select international markets with over 150 products. The Company monitors investments in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by the Company such as Exelon and Impavido.

Webull offers Knight Therapeutics Inc stock information, including OTCPK: KHTRF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KHTRF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KHTRF stock methods without spending real money on the virtual paper trading platform.